Australia markets closed

Protalix BioTherapeutics, Inc. (PLX)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
1.1500-0.0300 (-2.54%)
At close: 04:00PM EDT
1.1500 0.00 (0.00%)
After hours: 06:04PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. Estimate-0.02-0.020.210.81
Low estimate-0.02-0.020.210.81
High estimate-0.02-0.020.210.81
Year ago EPS-0.070.210.090.21
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. Estimate9.2M8.9M74.06M127.35M
Low estimate9.2M8.9M74.06M127.35M
High estimate9.2M8.9M74.06M127.35M
Year ago salesN/A35.08M65.49M74.06M
Sales growth (year/est)N/A-74.60%13.10%72.00%
Earnings history30/12/202229/06/202329/09/202330/12/2023
Est. EPS-0.15-0.04-0.07-0.03
Actual EPS-0.070.21-0.04-0.07
Difference0.080.250.03-0.04
Surprise %53.30%625.00%42.90%-133.30%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.02-0.020.210.81
7 days ago-0.02-0.020.210.81
30 days ago-0.02-0.020.140.81
60 days ago-0.02-0.020.140.81
90 days ago-0.02-0.020.140.81
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesPLXIndustrySector(s)S&P 500
Current qtr.71.40%N/AN/AN/A
Next qtr.-109.50%N/AN/AN/A
Current year133.30%N/AN/AN/A
Next year285.70%N/AN/AN/A
Next 5 years (per annum)25.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A